# Sunshine Biopharma Inc.: Form 8-K/A, filed Dec 12, 2022

- Company: [Sunshine Biopharma Inc.](/companies/sbfm.md) (CIK 1402328)
- Form: 8-K/A
- Filed: 2022-12-12
- Accepted by EDGAR: Dec 12, 2022, 16:31 ET
- Period: 2022-10-20
- Accession: 0001683168-22-008357
- Inline XBRL: yes
- Main document: https://www.sec.gov/Archives/edgar/data/1402328/000168316822008357/sunshine_8ka.htm
- All documents and exhibits: https://www.sec.gov/Archives/edgar/data/1402328/000168316822008357/

## Items reported

- Item 9.01: Financial statements and exhibits

## Sections

Sections are extracted only from 10-K and 10-Q reports. Read this filing’s documents on sec.gov. https://www.sec.gov/Archives/edgar/data/1402328/000168316822008357/sunshine_8ka.htm

Filed Dec 12, 2022.
Source: SEC EDGAR, the filing index for accession 0001683168-22-008357. Last ingested by Listed: Nov 11, 2026, 03:50 ET. No prices; not investment advice.